03.11.2014 Views

ReseaRch Quality assuRance foR the futuRe a ... - Lund University

ReseaRch Quality assuRance foR the futuRe a ... - Lund University

ReseaRch Quality assuRance foR the futuRe a ... - Lund University

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Panel 10 – medicine | Laboratory<br />

Cancer Stem cell Program<br />

No separate description is provided for this program. Review of <strong>the</strong><br />

publications provided it is obvious that throughout <strong>the</strong> HSC and NSC<br />

programs, as well as in <strong>the</strong> area of functional genomics, significant effort<br />

is placed in study of cancer stem cells, in <strong>the</strong> areas of leukemia, CNS<br />

cancer and breast cancer. A number of excellent to outstanding senior and<br />

young investigators are involved in this research line.<br />

4.3 Strategic planning<br />

The Center has excelled in <strong>the</strong> development of basic research lines in<br />

HSC and NSC biology, cancer stem cells and to a lesser degree developmental<br />

biology.<br />

The Center plans to continue to build on <strong>the</strong> existing programs that<br />

are focused chiefly on basic science, and develop <strong>the</strong> Center to include<br />

translational research. They identify five areas wherein development of<br />

basic-translational research is planned. The areas identified are of great<br />

basic science interest to <strong>the</strong> Center and <strong>the</strong> field in general, and have<br />

obviously even greater clinical impact significance. This was apparently<br />

also strongly supported by <strong>the</strong> EAB to <strong>the</strong> Center.<br />

a. The area of hematopoiesis and cancer stem cells, in particular in <strong>the</strong><br />

area of leukemia, are a logical extension from <strong>the</strong> studies that are<br />

currently ongoing in <strong>the</strong> labs of <strong>the</strong> basic biologists, and <strong>the</strong> existing<br />

strengths in more clinical research.<br />

b. During discussions with <strong>the</strong> department head, it became clear that <strong>the</strong><br />

move to include more translational research in neurobiology, is well<br />

reasoned, and well planned, and should become possible due to <strong>the</strong><br />

fact that clinicians have been enthused regarding <strong>the</strong> idea, and some<br />

of <strong>the</strong> junior as well as more senior faculty have been able to exploit<br />

<strong>the</strong> Linne funds to have a direct clinical link. Moreover, European<br />

funding was also secured in this area.<br />

c. The area of cardiovascular research is to some extent new to <strong>the</strong><br />

Center, even though one of <strong>the</strong> members of <strong>the</strong> hematopoietic stem<br />

cell program has been active in <strong>the</strong> area. Offline discussions have<br />

indicated that European funding has been secured in this area to<br />

allow indeed <strong>the</strong> development of this line of research.<br />

d. Although work is being done in <strong>the</strong> area of beta cell differentiation<br />

from embryonic stem cells, only two investigators are listed in this<br />

area. Moreover, <strong>the</strong> move to clinical application of stem cell research<br />

296

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!